Changes in immunological parameters in lung cancer patients undergoing immunotherapy with streptococcal preparation OK-432

[1]  A. Uchida,et al.  Production of interleukin 6 by human spleen cells stimulated with streptococcal preparation OK-432. , 1989, Immunology letters.

[2]  Y. Yagi,et al.  Immunotherapy of patients with terminal-stage malignant tumors with an immunopotentiator OK-432--a comparison of SU-PS test-responding and -nonresponding patients. , 1988, International journal of immunopharmacology.

[3]  K. Teshima,et al.  Immunotherapy using the streptococcal preparation OK‐432 for the treatment of uterine cervical cancer. Cervical Cancer Immunotherapy Study Group , 1989, Cancer.

[4]  T. Noda,et al.  Interferon‐γ Induction in Human Peripheral Blood Mononuclear Cells by OK‐432, a Killed Preparation of Streptococcus pyogenes , 1986, Microbiology and immunology.

[5]  T. Iwa,et al.  Immunotherapy of lung cancer: a randomized clinical trial of OK-432 immunotherapy and a review of the literature on nonspecific immunotherapy , 1986 .

[6]  A. Meager,et al.  Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432. , 1986, International journal of immunopharmacology.

[7]  Y. Fujiwara,et al.  Studies of natural killer activity and augmentation by OK-432 in patients with gynecological malignancies. , 1986, Gynecologic and obstetric investigation.

[8]  T. Iwa,et al.  Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK‐432 , 1984, Cancer.

[9]  A. Mantovani,et al.  Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells. , 1983, British Journal of Cancer.

[10]  A. Uchida,et al.  Intrapleural administration of OK432 in cancer patients: Activation of nk cells and reduction of suppressor cells , 1983, International journal of cancer.

[11]  N. Minato,et al.  In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432. , 1982, Journal of the National Cancer Institute.

[12]  M. Mckneally,et al.  Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer. , 1981, The Journal of thoracic and cardiovascular surgery.

[13]  A. Uchida,et al.  Clinical studies on cell‐mediated immunity in patients with malignant disease I. Effect of immunotherapy with OK‐432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro , 1980 .

[14]  Amery Wk.  Final results of a multicenter placebo-controlled levamisole study of resectable lung cancer. , 1978 .

[15]  B. Milleron,et al.  Immunochemotherapy in 34 cases of oat cell carcinoma of the lung with 19 complete responses. , 1977, Cancer treatment reports.

[16]  M. Ohta,et al.  Immunotherapy of human lung cancer with BCG cell-wall skeleton. , 1976, Gan.